Suppr超能文献

亚油酸氧化代谢产物作为非酒精性脂肪性肝炎肝损伤的生物标志物

Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

作者信息

Santoro Nicola, Caprio Sonia, Feldstein Ariel E

机构信息

Yale University, Pediatrics, New Haven, CT, USA.

Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.

出版信息

Clin Lipidol. 2013 Aug 1;8(4):411-418. doi: 10.2217/clp.13.39.

Abstract

The rising prevalence of obesity in the last few decades has been accompanied by an increase in nonalcoholic fatty liver disease (NAFLD). NAFLD encompasses a spectrum of liver pathology from isolated hepatic steatosis to steatohepatitis and advanced fibrosis. Dietary habits characterized by consumption of high-caloric, lipid-rich diets play a major role in the development of NAFLD. Recent studies have uncovered the importance of certain components of the diet. In this review, we will focus on the growing evidence for a central role of n-6 polyunsaturated fatty acids. We will discuss novel findings linking oxidative stress and increased production of reactive oxygen species in the liver to oxidation of n-6 polyunsaturated fatty acids and production of specific lipid oxidation metabolites. In particular, we will highlight the potential role of these metabolites as noninvasive markers to diagnose and monitor the extent of liver damage in patients with NAFLD.

摘要

在过去几十年里,肥胖症患病率的不断上升伴随着非酒精性脂肪性肝病(NAFLD)的增加。NAFLD涵盖了从单纯性肝脂肪变性到脂肪性肝炎和晚期纤维化的一系列肝脏病理情况。以高热量、高脂肪饮食为特征的饮食习惯在NAFLD的发展中起主要作用。最近的研究揭示了饮食中某些成分的重要性。在这篇综述中,我们将聚焦于越来越多的证据表明n-6多不饱和脂肪酸起着核心作用。我们将讨论将肝脏中的氧化应激和活性氧生成增加与n-6多不饱和脂肪酸氧化及特定脂质氧化代谢产物生成联系起来的新发现。特别是,我们将强调这些代谢产物作为非侵入性标志物在诊断和监测NAFLD患者肝损伤程度方面的潜在作用。

相似文献

3
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22.
4
The role of oxidized lipid species in insulin resistance and NASH in children.
Front Endocrinol (Lausanne). 2022 Oct 3;13:1019204. doi: 10.3389/fendo.2022.1019204. eCollection 2022.
5
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
6
Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease.
Annu Rev Nutr. 2013;33:231-48. doi: 10.1146/annurev-nutr-071812-161230.
8
Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
Free Radic Biol Med. 2004 Nov 1;37(9):1499-507. doi: 10.1016/j.freeradbiomed.2004.06.033.
9
Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G320-7. doi: 10.1152/ajpgi.00181.2013. Epub 2013 Dec 19.
10
The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.
Children (Basel). 2017 Jun 6;4(6):46. doi: 10.3390/children4060046.

引用本文的文献

5
The association between eicosanoids and incident atrial fibrillation in the Framingham Heart Study.
Sci Rep. 2022 Nov 23;12(1):20218. doi: 10.1038/s41598-022-21786-0.
9
Oxylipin Profiles in Plasma of Patients with Wilson's Disease.
Metabolites. 2020 May 29;10(6):222. doi: 10.3390/metabo10060222.

本文引用的文献

1
Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis.
J Hepatol. 2013 Sep;59(3):563-70. doi: 10.1016/j.jhep.2013.04.025. Epub 2013 May 9.
3
PNPLA3/adiponutrin functions in lipid droplet formation.
Biol Cell. 2013 May;105(5):219-233. doi: 10.1111/boc.201200036. Epub 2013 Apr 17.
5
Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
J Clin Invest. 2012 Nov;122(11):4130-44. doi: 10.1172/JCI65179.
6
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans.
Prostaglandins Leukot Essent Fatty Acids. 2012 Oct-Nov;87(4-5):135-41. doi: 10.1016/j.plefa.2012.08.004. Epub 2012 Sep 5.
8
Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.
Cell Metab. 2012 May 2;15(5):691-702. doi: 10.1016/j.cmet.2012.04.008.
10
The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease.
J Hepatol. 2012 Aug;57(2):468-9; author reply 469-70. doi: 10.1016/j.jhep.2012.01.028. Epub 2012 Mar 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验